RNS Number : 2410Y
Feedback PLC
08 September 2025
Feedback plc
Notice of Results & Retail Investor Presentation
Feedback plc (AIM: FDBK, "Feedback" or the "Company"), the clinical infrastructure specialist, expects to announce results for the 12 months ended 31 May 2025 (the "Period") on Wednesday 17 September 2025.
Investor Presentation: 16:00, Wednesday 17 September
Management will be providing a presentation and hosting an investor Q&A session on the Company's results and future prospects on Wednesday 17 September at 16:00. Investors can sign up for free and register to meet FDBK via the following link: https://www.investormeetcompany.com/feedback-plc/register-investor
Investors who have already registered on the Investor Meet Company platform to meet the Company will automatically be invited.
--Ends--
Enquiries:
Feedback plc Tom Oakley, CEO Anesh Patel, CFO
+44 (0) 20 3997 7634 IR@fbk.com
Panmure Liberum Limited (NOMAD and Broker) Emma Earl/ Mark Rogers (Corporate Finance) Rupert Dearden (Corporate Broking)
+44 (0)20 7886 2500
Walbrook PR Ltd;
Tel: 020 7933 8780 orfeedbackplc@walbrookpr.com
Nick Rome/Joe Walker
07748 325 236 or 07407 020 470
About Feedback plc
Feedback plc liberates the data and knowledge from multiple healthcare IT systems and delivers better workflow to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. We connect care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.
By linking different clinical systems together into a seamless view of the patient, we can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.
Bleepa® is our communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance. CareLocker® is our patient-facing platform that gives patients access and control over their diagnostic and other clinical data.
The Company has a number of growth opportunities domestically and internationally across a range of public and private healthcare markets including the NHS. Our highly scalable software-as-a-service (SaaS) based model is expected to provide increasing levels of revenue visibility as the Company grows its customer base.
https://feedbackmedical.com/
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
NORLAMMTMTTMBLA
